In addition, shedding of ALCAM results in the increase of sALCAM in the serum of ovarian [28] and breast cancer patients [21], suggesting a potential role of sALCAM as tumor biomarker, although lower levels are also present in the plasma of healthy individuals [29]. This evidence concerns the gene ALCAM and breast cancer.